{"SPADE_UN_17327": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17327", "Peptide Name": "IRQ", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "IRQRRRR", "Sequence Length": 7, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Conjugation to solid lipid nanoparticle", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C41H81N23O9", "Mass": 1040.23, "PI": 12.0, "Net Charge": 5, "Hydrophobicity": -3.07, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Literature": [{"Title": "Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.", "Pubmed ID": "24968819", "Reference": "Eur J Pharm Biopharm. 2014 Oct;88(2)518-29.", "Author": "an T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=24968819"}], "Frequent Amino Acids": "RIQ", "Absent Amino Acids": "ACDEFGHKLMNOPSTUVWY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 1, "Polar Residues": 6, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_03247", "Similarity": 1.0, "Sequence": "RRWRIVVIRQRR"}, {"SPADE_ID": "SPADE_UN_03741", "Similarity": 1.0, "Sequence": "RRAAVVLIVIRQ"}, {"SPADE_ID": "SPADE_UN_05157", "Similarity": 1.0, "Sequence": "VRLRIRVAVIRQ"}]}}}